Ixekizumab Improves Self-reported Overall Functioning and Health as Measured by the Assessment of SpondyloArthritis International Society Health Index in Patients with Active Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Randomized Trials

被引:0
|
作者
Kiltz, Uta [1 ]
van der Heijde, Desiree [2 ]
Boonen, Annelies [3 ]
Gensler, Lianne [4 ]
Hunter, Theresa [5 ]
Zhao, Fangyi [5 ]
Zhu, Baojin [5 ]
Bolce, Rebecca [5 ]
Carlier, Hilde [5 ]
Braun, Juergen [6 ]
机构
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
[6] Ruhr Univ, Rheumazentrum Ruhrgebiet, Herne, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1547
引用
收藏
页数:5
相关论文
共 40 条
  • [1] IXEKIZUMAB IMPROVES SELF-REPORTED OVERALL FUNCTIONING AND HEALTH AS MEASURED BY THE ASAS HEALTH INDEX IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL (COAST-X)
    Kiltz, U.
    Walsh, J. A.
    Vargas, R. B.
    Hunter, T.
    Bolce, R.
    Sandoval, D.
    Leage, S. Liu
    Leung, A.
    Li, X.
    Blue, E.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 722 - 722
  • [2] Ixekizumab Significantly Improves Patient-reported Overall Health as Measured by SF-36 in Patients with Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Trials
    Wei, Cheng-Chung
    Hunter, Theresa
    Van den Bosch, Filip
    Walsh, Jessica
    Kiltz, Uta
    Dong, Yan
    Sandoval, David
    Leon, Luis
    Strand, Vibeke
    Li, Xiaoqi
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials
    Kiltz, Uta
    Heijde, Desiree van der
    Boonen, Annelies
    Gensler, Lianne S.
    Gibble, Theresa Hunter
    Guo, Jiaying
    Carlier, Hilde
    Braun, Juergen
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (06) : 754 - 762
  • [4] IXEKIZUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED OVERALL HEALTH IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: SF-36 RESULTS OF TWO PHASE 3 TRIALS
    Walsh, Jessica A.
    Kiltz, Uta
    Wei, James Cheng-Chung
    van den Bosch, Filip
    Hunter, Theresa
    Dong, Yan
    Li Xiaoqi
    Sandoval, David
    Leon, Luis
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 898 - 899
  • [5] Ixekizumab Significantly Improves Self-reported Overall Health as Measured by Short-Form-36 in Patients with Active Non-radiographic Axial Spondyloarthritis: 16-and 52-Week Results of a Phase 3 Randomized Trial (COAST-X)
    Walsh, Jessica
    Magrey, Marina
    Kiltz, Uta
    Baraliakos, Xenofon
    Weng, Maggie
    Hunter, Theresa
    Li, Xiaoqi
    Leon, Luis
    Sandoval, David
    Inui, Kentaro
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] IXEKIZUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED OVERALL HEALTH AS MEASURED BY SF-36 IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS NAIVE TO BIOLOGICAL THERAPY: 52 WEEK RESULTS OF A PHASE 3 TRIAL
    Wei, James Cheng-Chung
    van den Bosch, Filip
    Walsh, Jessica A.
    Kiltz, Uta
    Hunter, Theresa
    Dong, Yan
    Leung, Ann
    Sandoval, David
    Leon, Luis
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1817 - 1818
  • [7] Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial
    Walsh, Jessica A.
    Magrey, Marina N.
    Baraliakos, Xenofon
    Inui, Kentaro
    Weng, Meng-Yu
    Lubrano, Ennio
    van der Heijde, Desiree
    Boonen, Annelies
    Gensler, Lianne S.
    Strand, Vibeke
    Braun, Juergen
    Hunter, Theresa
    Li, Xiaoqi
    Zhu, Baojin
    Leon, Luis
    Calderon, David Marcelino Sandoval
    Kiltz, Uta
    ARTHRITIS CARE & RESEARCH, 2022, 74 (03) : 451 - 460
  • [8] Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies
    Kiltz, Uta
    Wei, James Cheng-Chung
    van der Heijde, Desiree
    van den Bosch, Filip
    Walsh, Jessica A.
    Boonen, Annelies
    Gensler, Lianne S.
    Hunter, Theresa
    Carlier, Hilde
    Dong, Yan
    Li, Xiaoqi
    Bolce, Rebecca
    Strand, Vibeke
    Braun, Juergen
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (02) : 188 - 197
  • [9] Ixekizumab Significantly Improves Self-Reported Overall Functioning and Health in Patients with Active As/Radiographic Axial Spa Naive to Biologic DMARD Therapy: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial
    Kiltz, Uta
    van der Heijde, Desiree
    Boonen, Annelies
    Gensler, Lianne S.
    Hunter, Theresa
    Zhao, Fangyi
    Carlier, Hilde
    Braun, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16-and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
    Xue, Yu
    Hu, Jiankang
    Liu, Dongzhou
    Li, Jingyang
    Wu, Huaxiang
    Tan, Chunyu
    Dai, Lie
    Sun, Lingyun
    Li, Zhijun
    Xiao, Zhengyu
    Huang, Cibo
    Yan, Yan
    Ji, Fei
    Chen, Rong
    Zou, Hejian
    BIODRUGS, 2024, 38 (01) : 145 - 156